Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
extensively hydrolyzed rice protein formula
United Therapeutics Europe Ltd
Milk Hypersensitivity
1 trial -
fludeoxyglucose F 18
United Therapeutics Europe Ltd
Lung Cancer
1 trial -
fludeoxyglucose F 18
United Therapeutics Europe Ltd
Testicular Germ Cell Tumor
1 trial -
goserelin acetate
United Therapeutics Europe Ltd
Breast Cancer
1 trial -
morphine
Hospital Authority, Hong Kong
Pain Postoperative
1 trial -
multi-factorial intervention
United Therapeutics Europe Ltd
Type 2 Diabetes Mellitus
1 trial -
multi-vitamin carbohydrate
The First People's Hospital of Lianyungang
Nausea and Vomiting, Aspiration, Intraoperative
1 trial -
new extensively hydrolysed formula
United Therapeutics Europe Ltd
Protein Allergy
1 trial -
new infant formula
United Therapeutics Europe Ltd
Functional Constipation
1 trial -
only antiemetic (Ramosetron, Tropisetron and dexamethasone)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Chemotherapy-induced Nausea and Vomiting
1 trial -
oxytocin and misoprostol
United Therapeutics Europe Ltd
Postpartum Hemorrhage
1 trial -
parecoxib
The First People's Hospital of Lianyungang
Pain, Postoperative
1 trial -
phosphatidylcholine
Ultragenyx UK Limited
Methionine Adenosyltransferase Deficiency
1 trial -
phytic acid
United Therapeutics Europe Ltd
Iron-deficiency
1 trial -
postbiotics
Xiyuan Hospital of China Academy of Chinese Medical Sciences
ADHD - Attention Deficit Disorder With Hyperactivity
1 trial -
postoperative adjuvant chemotherapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Small-cell Lung Cancer
1 trial -
prazosin hydrochloride
United Therapeutics Europe Ltd
Alcohol Use Disorders
1 trial -
preoperative oral carbohydrate drink
The First People's Hospital of Lianyungang
Gastric Cancer
1 trial -
probiotics
The First People's Hospital of Lianyungang
Ulcerative Colitis
1 trial -
prochlorperazine and benadryl IV
United Therapeutics Europe Ltd
Acute Migraine Headache
1 trial -
progastrin
Grace Therapeutics
Colon Cancer Screening
1 trial -
radiochemotherapy 1
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Non Small Cell Lung Cancer
1 trial -
remimazolam
Xiyuan Hospital of China Academy of Chinese Medical Sciences
General Anesthetic Drug Adverse Reaction
1 trial -
rice formula
United Therapeutics Europe Ltd
Cow Milk Allergy
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources